Impax Laboratories, Inc. (NASDAQ: IPXL) revealed Tuesday that it reached definitive agreements with Teva Pharmaceutical Industries Ltd. (NYSE: TEVA) and affiliates of Allergan plc (NYSE: AGN) for the ...
Impax Large Cap Fund is a core US equities strategy that invests in companies with attractive valuations and sustainability ...
HAYWARD, Calif. & CUPERTINO, Calif.--(BUSINESS WIRE)-- Impax Laboratories, Inc.(NASDAQ:IPXL) and DURECT Corporation (Nasdaq:DRRX) announced today that they have entered into an agreement granting ...
Impax Asset Management ((GB:IPX)) has held its Q4 earnings call. Read on for the main highlights of the call. Claim 60% off TipRanks Premium for data-backed insights and research tools you need to ...
(Reuters) - Amneal Pharmaceuticals LLC is buying fellow generics drug maker Impax Laboratories Inc (IPXL.O) in an all-stock deal as a bulwark against a tough drug pricing environment. The deal comes ...
In response to receiving a double dose of good news from the Food and Drug Administration (FDA) and some bullish commentary from Wall Street, shares of Impax Laboratories (NASDAQ: IPXL), a maker of ...
Deal follows jury's rejection of claims against co-defendant Endo Plaintiffs' lawyers to seek up to $58 million in legal fees (Reuters) - Impax Laboratories on Tuesday said it had agreed to pay, opens ...
Amneal Pharmaceuticals and Impax Laboratories confirmed today that they are joining forces. Once the all-stock transaction is complete, Amneal's shareholders will own approximately 75% of the newly ...
Impax Laboratories, Inc. IPXL and privately held generic drug maker, Amneal Pharmaceuticals LLC announced that they have entered into an all stock deal to merge and form a new publicly traded ...
BOSTON (Reuters) - Impax Laboratories Inc has agreed to pay $20 million to consumers and insurers to resolve claims that the drugmaker entered an anticompetitive deal to delay launching a generic, ...
Amneal Pharmaceuticals and Impax Laboratories will combine to form the fifth largest generics business in the country, based on revenue. Here are four things to know about the deal. 1. Under the ...
Impax Small Cap Fund portfolio gave up some gains from the previous quarter and trailed the Russell 2000 Index. Read more ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results